TW200902092A - Aliphatic acid-containing N-halogenated amino acid formulations - Google Patents

Aliphatic acid-containing N-halogenated amino acid formulations Download PDF

Info

Publication number
TW200902092A
TW200902092A TW097115864A TW97115864A TW200902092A TW 200902092 A TW200902092 A TW 200902092A TW 097115864 A TW097115864 A TW 097115864A TW 97115864 A TW97115864 A TW 97115864A TW 200902092 A TW200902092 A TW 200902092A
Authority
TW
Taiwan
Prior art keywords
formulation
acid
amino acid
halogenated amino
acetate
Prior art date
Application number
TW097115864A
Other languages
English (en)
Chinese (zh)
Inventor
Masood A Chowhan
Wesley Wehsin Han
L Wayne Schneider
David W Stroman
Original Assignee
Alcon Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Res Ltd filed Critical Alcon Res Ltd
Publication of TW200902092A publication Critical patent/TW200902092A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Eyeglasses (AREA)
TW097115864A 2007-05-01 2008-04-30 Aliphatic acid-containing N-halogenated amino acid formulations TW200902092A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91527107P 2007-05-01 2007-05-01

Publications (1)

Publication Number Publication Date
TW200902092A true TW200902092A (en) 2009-01-16

Family

ID=39616420

Family Applications (1)

Application Number Title Priority Date Filing Date
TW097115864A TW200902092A (en) 2007-05-01 2008-04-30 Aliphatic acid-containing N-halogenated amino acid formulations

Country Status (17)

Country Link
US (2) US20080275126A1 (enExample)
EP (1) EP2139520B1 (enExample)
JP (2) JP2010526084A (enExample)
KR (1) KR20100017156A (enExample)
CN (1) CN101678105A (enExample)
AR (1) AR066371A1 (enExample)
AU (1) AU2008245460B2 (enExample)
BR (1) BRPI0811073A2 (enExample)
CA (1) CA2684101A1 (enExample)
CL (1) CL2008001283A1 (enExample)
ES (1) ES2432408T3 (enExample)
MX (1) MX2009011817A (enExample)
RU (1) RU2009144291A (enExample)
TW (1) TW200902092A (enExample)
UY (1) UY31057A1 (enExample)
WO (1) WO2008134692A1 (enExample)
ZA (1) ZA200907052B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2265267B1 (en) * 2008-04-10 2016-09-21 Waldemar Gottardi Compositions comprising n-halogenated or n, n-dihalogenated amine for treatment and prophylaxis of bronchopulmonary infections
WO2009127924A1 (en) * 2008-04-15 2009-10-22 Waldemar Gottardi Compositions and devices for antisepsis and anticoagulation
CN113729039A (zh) * 2021-08-27 2021-12-03 上海罗克环控节能科技股份有限公司 一种绿色环保消毒液及其制造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6027965B2 (ja) * 1980-02-23 1985-07-02 東洋コンタクトレンズ株式会社 コンタクトレンズに付着した汚れの除去方法
US5421818A (en) * 1993-10-18 1995-06-06 Inner Ear Medical Delivery Systems, Inc. Multi-functional inner ear treatment and diagnostic system
AU3070395A (en) * 1994-07-22 1996-02-22 Alcon Laboratories, Inc. Use of low molecular weight amino acids in ophthalmic compositions
US6156728A (en) * 1996-11-01 2000-12-05 Genentech, Inc. Treatment of inner ear hair cells
US6387427B1 (en) * 2000-09-28 2002-05-14 Nestec S.A. Method of preservation of a food product
WO2003061566A2 (en) * 2002-01-24 2003-07-31 Yissum Research Development Company Of The Hebrew University Of Jerusalem Anti-cancer combination and use thereof
PL1656095T3 (pl) * 2003-08-18 2014-04-30 Novabay Pharmaceuticals Inc N,n-dwuchlorowcowane kwasy aminowe i pochodne
TWI386201B (zh) * 2005-01-25 2013-02-21 Novabay Pharmaceuticals Inc Ｎ-鹵化胺基酸、ｎ，ｎ-二鹵化胺基酸與其衍生物；以及使用其之組合物與方法
TWI432231B (zh) * 2005-10-06 2014-04-01 Novabay Pharmaceuticals Inc 使用ｎ-鹵化胺基酸於預防包括泌尿道感染（ｕｔｉ）之細菌性與真菌性感染的系統與方法

Also Published As

Publication number Publication date
CA2684101A1 (en) 2008-11-06
BRPI0811073A2 (pt) 2014-12-09
UY31057A1 (es) 2008-10-31
KR20100017156A (ko) 2010-02-16
MX2009011817A (es) 2009-11-13
CN101678105A (zh) 2010-03-24
RU2009144291A (ru) 2011-06-10
JP2010526084A (ja) 2010-07-29
WO2008134692A1 (en) 2008-11-06
ES2432408T3 (es) 2013-12-03
EP2139520B1 (en) 2013-08-21
ZA200907052B (en) 2010-12-29
EP2139520A1 (en) 2010-01-06
AR066371A1 (es) 2009-08-12
JP2014098037A (ja) 2014-05-29
US20080275126A1 (en) 2008-11-06
AU2008245460B2 (en) 2013-08-22
CL2008001283A1 (es) 2009-01-16
US20110060044A1 (en) 2011-03-10
AU2008245460A1 (en) 2008-11-06

Similar Documents

Publication Publication Date Title
EP3650012A1 (en) Solid composition comprising iodine agent and sodium chloride having improved water solubility, and antiviral and antimicrobial composition for eye, oral cavity, nasal cavity or inhalation containing aqueous solution thereof
US20080021068A1 (en) Aqueous gel formulation and method for inducing topical anesthesia
JP2013082752A (ja) フルニソリド含有粘膜適用組成物
TW200902093A (en) N-halogenated amino acid formulations
TW200901957A (en) N-halogenated amino acid formulations with anti-inflammatory compounds
US20100204181A1 (en) N-halogenated amino acid formulations comprising phosphine or amine oxides
US20200289552A1 (en) Solid composition comprising iodine agent and sodium chloride having improved water solubility, and antiviral and antimicrobial composition for eye, oral cavity, nasal cavity or inhalation containing aqueous solution thereof
JPH02196716A (ja) 薬学的溶液
TW200902092A (en) Aliphatic acid-containing N-halogenated amino acid formulations
TW200934533A (en) Antimicrobial N-halogenated amino acid salts
WO2021202332A1 (en) Aqueous formulations containing povidone iodine for effective treatment and prevention of virus infections
JP2568233B2 (ja) 医薬組成物
UA115454C2 (uk) Композиція фінафлоксацину у вигляді суспензії